Bioavailability of lansoprazole granules administered in juice or soft food compared with the intact capsule formulation

Clinical Therapeutics

Volumn 24, Issue 8, 2002, Pages 1322-1331

  Chun, Alexander H C ^a   Erdman, Keith ^b   Chiu, Yi Lin ^a   Pilmer, Betsy L ^b   Achari, Ramanuj ^a   Cavanaugh, John H ^a  

^a ABBOTT LABORATORIES   (United States)

^b TAP PHARMACEUTICAL PRODUCTS INC   (United States)

Author keywords

Alternative dosage forms; Lansoprazole; Lansoprazole granules

Indexed keywords

LANSOPRAZOLE; WATER;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG FORMULATION; DRUG GRANULATION; DRUG GRANULE; DRUG TOLERABILITY; DYSPHAGIA; ENCAPSULATION; ENTERIC COATED TABLET; FEMALE; FOOD; FRUIT JUICE; HEADACHE; HUMAN; LIQUID; LIVER TOXICITY; MALE; NORMAL HUMAN; ORANGE JUICE; PEAR; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TOMATO; VOLUNTEER;

EID: 0036676079     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(02)80036-4     Document Type: Article

References (24)

1. Acid suppression in duodenal ulcer: A meta-analysis to define optimal dosing with antisecretory drugs
2. Is there an optimal degree of acid suppression in healing duodenal ulcer? A model of the relationship between ulcer healing and acid suppression
3. Appropriate acid suppression for the management of gastro-oesophageal reflux disease
4. Lansoprazole achieves faster control of intragastric acidity than pantoprazole
5. Lansoprazole achieves faster control of intragastric acidity than rabeprazole within the first 5 hours of administration
6. Time to maximum effect of lansoprazole on gastric pH in normal male volunteers
7. Are there any differences in symptom relief and healing esophagitis between proton pump inhibitors (PPIs): A meta-analysis of comparative trials
8. Lansoprazole: An alternative method of administration of a capsule dosage formulation
9. Lansoprazole: Administration of the contents of a capsule dosage formulation through a nasogastric tube
10. Effect on bioavailability of admixing the contents of lansoprazole capsules with selected soft foods
11. The pharmacodynamics of lansoprazole administered via gastrostomy as intact, non-encapsulated granules
12. Lansoprazole effectively suppresses intragastric acidity when administered via gastrostomy as intact granules in orange juice
13. Simplified lansoprazole suspension (SLS): A proton pump inhibitor (PPI) in a liquid formulation that works
14. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole
15. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability
16. Simplified omeprazole solution for the prophylaxis of stress-related mucosal damage in critically ill patients
17. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage
18. A multicenter, prospective, randomized clinical trial of continuous infusion IV ranitidine vs. omeprazole suspension in the prophylaxis of stress ulcers
19. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients
20. Alternative methods of proton pump inhibitor administration
21. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children
22. Omeprazole for chronic erosive esophagitis in children: A multicenter study of dose requirement for healing
23. Importance of pH control in the management of GERD